CHROMOSOMAL DISEASES IN THE HUMAN PATHOLOGY

(review)

Authors

DOI:

https://doi.org/10.11603/ijmmr.2413-6077.2020.1.11501

Keywords:

Down syndrome, Klinefelter syndrome, Turner syndrome, double aneuploidy

Abstract

Background. Chromosomal diseases are the cause of 45-50 % of multiple birth defects. Basic research on mutations is performed using genomic technologies to identify a correlation between genotype and phenotype in aneuploidies and to understand its pathogenesis.

Objective. The aim of the research is to study the etiology, pathogenesis of symptoms and diagnostics for patients with Down, Klinefelter, Turner syndromes and double aneuploidies by 21 and sex chromosomes.

Methods. A literature review by the keywords “Down syndrome”, “Klinefelter syndrome”, “Turner syndrome”, “double aneuploidy” for the period of 2000-2020 was carried out.

Results. Down, Klinefelter and Turner syndromes are the most common aneuploidy among viable newborns. Frequency of meiotic non-disjunction events causing these aneuploidies increases with the age of a woman. Identified genes are responsible for pathogenesis of symptoms in trisomy 21, Turner and Klinefelter syndromes. Diagnostics of chromosomal diseases includes prenatal screening programs and postnatal testing.

Conclusions. Cytogenetic variants of Down syndrome are simple complete trisomy 21, translocation form and mosaicism. Trisomy 21 is associated with advanced maternal age. Phenotypic manifestations of Down syndrome are associated with the locus 21q22. The maternal and parental nondisjunction of X-chromosomes in meiosis causes Klinefelter and Turner syndromes. These chromosomal diseases are variants of intersexualism with intermediate chromosomal sex. Down-Klinefelter and Down-Turner syndromes are double aneuploidies. Patients have a Down syndrome phenotype at birth, and signs of Klinefelter and Turner syndromes occur during puberty. Diagnosis of aneuploidy is based on the cytogenetic investigation (karyotyping), DNA analysis, ultrasonography and biochemical markers of chromosomal pathology.

Author Biographies

T.V. Bihunyak, I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE

MD, Ph.D., Associate Professor, Department of Pathophysiology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

Yu. I. Bondarenko, I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE

MD, Ph.D., Professor, Department of Pathophysiology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

O. O. Кulyanda, I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE

Department of Pathophysiology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

S. M. Charnosh, I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE

MD, Ph.D., Associate Professor, Department of Pathophysiology, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

A. S. Sverstiuk, I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE

PhD, Associate Professor, Department of Medical Informatics, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

K. O. Bihuniak, I. HORBACHEVSKY TERNOPIL NATIONAL MEDICAL UNIVERSITY, TERNOPIL, UKRAINE

6th year student of the Faculty of Мedicine, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine

References

Bihunyak TV Current views on the causes and phenotypic manifestations of Down syndrome. The achievements of Clinical and Experimental medicine. 2008;1(8):7-11.

Protsyuk OV, Lynchak OV, Pokanevich TM Prevalence of chromosomal abnormalities among live births and stillbirths in Ukraine. Obstetrics. Gynecology. Genetics. 2017;3:37-41.

Kazemi M, Salehi M, Kheirollahi M Down Syndrome: Current Status, Challenges and Future Perspectives. Int J Mol Cell Med Summer. 2016; Vol 5 No 3:125-33.

Mathew AK, Amaladas AS, Ahmed A, Hameed S. Clinical Presentation of Down’s syndrome: A case re­port. The journal of medical research. 2017;3(3):107-9.

doi: 10.31254/jmr.2017.3304

Shankar RK, Backeljauw PF. Current best practice in the management of Turner syndrome. Therapeutic Advances in Endocrinology and Meta­bolism. 2018;9(1): 33-40.

doi: 10.1177/2042018817746291

Souza MP, Santos SM, Lima MM, Machado JM, Melo MM, Oliveira EH, Guerreiro JF. Chromosomal ana­lyses in genetic counseling of patients with deve­lopmental and congenital abnormalities from Belém, Pará State, Brazil: a retrospective study of 17 years.

doi: 10.5123/S2176-6223201901597

Bihunyak TV Hereditary syndromes of inter­sexualism with an intermediate chromosomal sex. The achievements of Clinical and Experimental medicine. 2008;2(9):9-14.

Chebel Z, Krayem S, Nassif Y, et al. When Edwards meets Klinefelter: a new case of double Aneuploidy. J Pediatr Neonatal Care. 2019;9(2):65-6.

Pinti E, Lengyel A, Fekete G, et al. What should we consider in the case of combined Down- and 47,XY,+i(X)(q10) Klinefelter syndromes? The unique case of a male newborn and review of the literature. BMC Pediatrics. 2020;20:17.

doi: 10.1186/s12887-019-1905-9

Lan RY, Chou CT, Wang PH, Chen RC, Hsiao CH. Trisomy 21 screening based on first and second trimester in a Taiwanese population. Taiwa­nese Journal of Obstetrics and Gynecology. 2018 Aug 1;57(4):551-4.

doi: 10.1016/j.tjog.2018.06.014

Dooley KJ. Congenital Heart Disease and Down Syndrome In: Rubin IL, Merrick J, Greydanus DE, et al., editors. Health Care for People with Intellectual and Developmental Disabilities across the Lifespan: Springer. 2016:1301-10.

doi: 10.1007/978-3-319-18096-0_105

English C, Hammersley AL, Jackson A, Sten­house S, Cross IE. Recurrent trisomy 21 resulting from gonadal mosaicism. Journal of Medical Gene­tics. 2001.

Coppedè F. Risk factors for Down syndrome. Archives of toxicology. 2016 Dec;90(12):2917-29.

doi: 10.1007/s00204-016-1843-3

PLAIASU V. Down syndrome–genetics and cardiogenetics. Maedica. 2017 Sep;12(3):208-13.

Gumus E. Two Rare Variants of Down Synd­rome: Down-Turner Syndrome and Down Syndrome with Translocation (13; 14): A Case Report. Iranian Journal of Public Health. 2019 Nov;48(11):2079-82.

doi: 10.18502/ijph.v48i11.3529

Zaki MS, Kamel AA, El-Ruby M. Double aneuploidy in three Egyptian patients: Down-Turner and Down-Klinefelter syndromes. Genetic counseling. 2005 Jan 1;16(4):393-402.

Belling K, Russo F, Jensen AB, Dalgaard MD, Westergaard D, Rajpert-De Meyts E, Skakkebæk NE, Juul A, Brunak S. Klinefelter syndrome comorbidities linked to increased X chromosome gene dosage and altered protein interactome activity. Human Mole­cular Genetics. 2017 Apr 1;26(7):1219-29.

doi: 10.1093/hmg/ddx014

Gnetetskaya VA, Kurtser MA, Malmberg OL. Early diagnosis of fetal chromosomal pathology using the OSCAR program. Obstetrics and Gyne­cology. 2010;1:24-8.

Shargorodska EB. A retrospective evaluation of the condition of newborns with congenital heart defects. Lviv Medical Journal Acta Medica Leopo­liensia. 2018;24(3):52-7.

doi: 10.25040/aml2018.03.052

Marder L, Tulloh R, Pascall E. Cardiac prob­lems in Down syndrome. Paediatrics and Child Health. 2015 Jan 1;25(1):29.

doi: 10.1016/j.paed.2014.07.011

Jacobs EG, Leung MP, Karlberg J. Distribution of symptomatic congenital heart disease in Hong Kong. Pediatric cardiology. 2000 Mar 1;21(2):148-57.

doi: 10.1007/s002469910025

Kim MA, Lee YS, Yee NH, Choi JS, Choi JY, Seo K. Prevalence of congenital heart defects asso­ciated with Down syndrome in Korea. Journal of Ko­­rean Medical Science. 2014 Nov 1;29(11):1544-9.

doi: 10.3346/jkms.2014.29.11.1544

de Rubens Figueroa J, del Pozzo Magaña B, Pablos Hach JL, Calderón Jiménez C, Castrejón Urbi­na R. Heart malformations in children with Down syndrome. Revista Española de Cardiología (English Edition). 2003 Sep 1;56(9):894-9.

doi: 10.1016/s0300-8932(03)76978-4

Vida VL, Barnoya J, Larrazabal LA, Gaitan G, de Maria Garcia F, Castañeda AR. Congenital cardiac disease in children with Down’s syndrome in Gua­temala. Cardiology in the Young. 2005 Jun;15(3):286-90.

doi: 10.1017/s1047951105000582

Elmagrpy Z, Rayani A, Shah A, et al. Down syndrome and congenital heart disease: why the regional difference as observed in the Libyan expe­rience? Cardiovasc J Afr. 2011;22:306-9.

doi: 10.5830/cvja-2010-072

Barlow GM, Chen XN, Shi ZY, Lyons GE, Kur­nit DM, Celle L, Spinner NB, Zackai E, Pettenati MJ, Van Riper AJ, Vekemans MJ. Down syndrome con­ge­nital heart disease: a narrowed region and a candi­date gene. Genetics in Medicine. 2001 Mar;3(2):91-101.

doi: 10.1097/00125817-200103000-00002

Calkoen EE, Hazekamp MG, Blom NA, Elders BB, Gittenberger-de Groot AC, Haak MC, Bartelings MM, Roest AA, Jongbloed MR. Atrioven­tricular septal defect: From embryonic development to long-term follow-up. International journal of cardiology. 2016 Jan 1;202:784-95.

doi: 10.1016/j.ijcard.2015.09.081

Ackerman C, Locke AE, Feingold E, Reshey B, Espana K, Thusberg J, Mooney S, Bean LJ, Dooley KJ, Cua CL, Reeves RH. An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects. The Ame­rican Journal of Human Genetics. 2012 Oct 5;91(4):646-59.

doi: 10.1016/j.ajhg.2012.08.017

Mateos MK, Barbaric D, Byatt SA, Sutton R, Marshall GM. Down syndrome and leukemia: insights into leukemogenesis and translational targets. Trans­lational pediatrics. 2015 Apr;4(2):76-92.

doi: 10.3978/j.issn.22244336.2015.03.03

Sobey CG, Judkins CP, Sundararajan V, Phan TG, Drummond GR, Srikanth VK. Risk of major cardiovascular events in people with Down syndrome. PloS one. 2015 Sep 30;10(9):e0137093.

doi: 10.1371/journal.pone.0137093

Matthews-Brzozowska T, Cudziło D, Walasz J, Kawala B. Rehabilitation of the orofacial complex by means of a stimulating plate in children with Down syndrome. Adv Clin Exp Med. 2015 Mar 1;24(2):301-5.

doi: 10.17219/acem/40451

Sixou JL, Vernusset N, Daigneau A, Watine D, Marin L. Orofacial therapy in infants with Down syndrome. Journal of Dentofacial Anomalies and Orthodontics. 2017;20(1):108.

doi: 10.1051/odfen/2016038

Radoi VE, Bohiltea CL, Bohiltea RE, Albu DN. Cell free fetal DNA testing in maternal blood of Ro­manian pregnant women. Iranian journal of repro­ductive medicine. 2015 Oct;13(10):623-6.

Smith-Bindman R, Miglioretti DL, Sentilhes L, Salomon LJ, Vayssière C, Norton ME, Wapner RJ. Cell-free DNA analysis for noninvasive examination of trisomy. New England Journal of Medicine. 2015 Dec 24;373(26):2581-2.

doi: 10.1056/nejmc1509344

Meck JM, Dugan EK, Matyakhina L, Aviram A, Trunca C, Pineda-Alvarez D, Aradhya S, Klein RT, Cherry AM. Noninvasive prenatal screening for aneuploidy: positive predictive values based on cytogenetic findings. American journal of obstetrics and gynecology. 2015 Aug 1;213(2):214 e1-214 e5.

doi: 10.1016/j.ajog.2015.04.001

Taylor-Phillips S, Freeman K, Geppert J, Ag­bebiyi A, Uthman OA, Madan J, Clarke A, Quenby S, Clarke A. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis. BMJ open. 2016 Jan 1;6(1).

doi: 10.1136/bmjopen-2015-010002

Fedorova NI, Tetruashvili NK, Demura TA et al. Importance of embryonic cells isolated from the cervical canal in early non-invasive prenatal diag­nosis. Obstetrics and Gynecology 2010;1:28-31.

Linglart A, Cabrol S, Berlier P, Stuckens C, Wagner KD, De Kerdanet M, Limoni C, Carel JC, Chaussain JL. Growth hormone treatment before the age of 4 years prevents short stature in young girls with Turner syndrome. European journal of endo­crinology. 2011 Jun 1;164(6):891-7.

doi: 10.1530/eje-10-1048

Gravholt CH, Andersen NH, Conway GS, Dekkers OM, Geffner ME, Klein KO, Lin AE, Mauras N, Quigley CA, Rubin K, Sandberg DE. Clinical practice guidelines for the care of girls and women with Tur­ner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting. European journal of endocrinology. 2017 Sep 1;177(3):G1-70.

doi: 10.1530/eje-17-0430

Knauer-Fischer S, Besikoglu B, Inta I, Kneppo C, Vogt PH, Bettendorf M. Analyses of gona­doblastoma Y (GBY)-locus and of Y centromere in Turner syndrome patients. Experimental and Clinical Endocrinology & Diabetes. 2015 Jan;123(01):61-5.

doi: 10.1055/s-0034-1387734

Lunding SA, Aksglæde L, Anderson RA, Main KM, Juul A, Hagen CP, Pedersen AT. AMH as predictor of premature ovarian insufficiency: a longi­tudinal study of 120 Turner syndrome patients. The Journal of Clinical Endocrinology & Metabolism. 2015 Jul 1;100(7):E1030-8.

doi: 10.1210/jc.2015-1621

Zaiem F, Alahdab F, Al Nofal A, Murad MH, Javed A. Oral versus transdermal estrogen in turner syndrome: a systematic review and meta-analysis. Endocrine Practice. 2017 Apr;23(4):408-21.

doi: 10.4158/ep161622.or

Lanfranco F, Kamischke A, Zitzmann M, Nieschlag E. Klinefelter’s syndrome. The Lancet. 2004 Jul 17;364(9430):273-83.

doi: 10.1016/S0140-6736(04)16678-6

Kondo T, Kuroda S, Usui K, et al. A case of a rare variant of Klinefelter syndrome, 47,XY,i(X)(q10). Andrologia. 2018;17:e13024.

doi: 10.1111/and.13024

Dürrbaum M, Storchova Z. Effects of aneu­ploidyon gene expression: implications for cancer. FEBSJ. 2016; 283,791-802.

doi: 10.1111/febs.13591

Seminog OO, Seminog AB, Yeates D, Goldacre MJ. Associations between Klinefelter’s syndrome and autoimmune diseases: English national record linkage studies. Autoimmunity. 2015 Feb 17;48(2): 125-8.

doi: 10.3109/ 08916934.2014.968918

Samango-Sprouse CA, Sadeghin T, Mitchell FL, Dixon T, Stapleton E, Kingery M, Gropman AL. Positive effects of short course androgen therapy on the neurodevelopmental outcome in boys with 47, XXY syndrome at 36 and 72 months of age. American Journal of Medical Genetics Part A. 2013 Mar;161(3): 501-8.

doi: 10.1002/ajmg.a.35769

Bozdogan ST, Bisgin A. A rare double aneuploidy case (Down–Klinefelter). Journal of pediatric genetics. 2017 Dec;6(4):241-3.

doi: 10.1055/s-0037-1604098

Bozdogan ST, Bisgin A. A rare double aneuploidy case (Down–Klinefelter). Journal of pediatric genetics. 2017 Dec;6(4):241-3.

doi: 10.1055/s-0037-1604098

Shen Z, Zou CC, Shang SQ, Jiang KW. Down-Klinefelter syndrome (48, XXY,+ 21) in a child with congenital heart disease: case report and literature review. Internal Medicine. 2012;51(11):1371-4.

doi: 10.2169/internalmedicine.51.7097

Kovaleva NV, Mutton DE. Epidemiology of double aneuploidies involving chromosome 21 and the sex chromosomes. American Journal of Medical Genetics Part A. 2005 Apr 1;134(1):24-32.

doi: 10.1002/ajmg.a.30306

Jeanty C, Turner C. Prenatal diagnosis of double aneuploidy, 48, XXY,+ 21, and review of the literature. Journal of Ultrasound in Medicine. 2009 May;28(5):673-81.

doi: 10.7863/jum.2009.28.5.673

Akgul M, Ozkinay F, Ercal D, Cogulu O, Dogan O, Altay B, Tavmergen E, Gunduz C, Ozkinay C. Cytogenetic abnormalities in 179 cases with male infertility in Western Region of Turkey: report and review. Journal of assisted reproduction and gene­tics. 2009 Mar 1;26(2-3):119-22.

doi: 10.1007/s10815-009-9296-8

Manassero-Morales G, Alvarez-Manassero D, Merino-Luna A. Down-Turner syndrome: A case with double monoclonal chromosomal abnormality. Case reports in pediatrics. 2016 Jan 1;2016.

doi: 10.1155/2016/8760504

Downloads

Published

2020-11-10

How to Cite

Bihunyak, T. ., Bondarenko, Y. I., Кulyanda O. O., Charnosh, S. M., Sverstiuk, A. S., & Bihuniak, K. O. (2020). CHROMOSOMAL DISEASES IN THE HUMAN PATHOLOGY: (review). International Journal of Medicine and Medical Research, 6(1), 50–60. https://doi.org/10.11603/ijmmr.2413-6077.2020.1.11501